CPBIO Holding Company Limited (HKG:3839)
Hong Kong · Delayed Price · Currency is HKD 8.65
-0.10 (-1.14%)
Aug 27, 2026, 3:01 PM HKT
CPBIO Holding Company Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 423.98 | 535.91 | 307.75 | 173.98 | 159.24 | 142.41 |
Revenue Growth | -18.95% | 74.14% | 76.89% | 9.26% | 11.82% | 52.18% |
Gross Profit Gross Profit Growth | 70.38 | 77.44 | 48.93 | 30.19 | 39.19 | 34.76 |
Operating Income Operating Income Growth | 29.97 | 38.89 | 11.18 | -4.54 | 4.88 | 4.97 |
Net Income Net Income Growth | 24.43 | 32.06 | 11.17 | 2.55 | -6.68 | 19.56 |
Earnings Per Share EPS Growth | 0.10 | 0.13 | 0.04 | 0.01 | -0.03 | 0.08 |
EPS Growth | -6.93% | 187.03% | 337.47% | - | - | 20.36% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Mainland China Mainland China Growth | 301.93 | 421.31 | 233.23 | 107.95 | 83.29 | 70.47 |
Asia Pacific (Excluding Mainland China) Asia Pacific (Excluding Mainland China) Growth | 56.27 | 47.33 | 27.38 | 28.73 | 24.35 | 27.11 |
Americas Americas Growth | 46.4 | 44.16 | 32.12 | 24.65 | 29.1 | 30.65 |
Europe and Elsewhere Europe and Elsewhere Growth | 19.37 | 23.11 | 15.03 | - | - | - |
Total Total Growth | 423.98 | 535.91 | 307.75 | 173.98 | 159.24 | 142.41 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 37.25 | 39.83 | 32.38 | 37.61 | 30.86 | 31.09 |
Total Debt Total Debt Growth | 75.58 | 47.4 | 69.17 | 78.17 | 49.1 | 42.61 |
Net Cash (Debt) Net Cash Growth | -38.32 | -7.57 | -36.79 | -40.56 | -18.24 | -11.52 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.15 | -0.03 | -0.15 | -0.16 | -0.07 | -0.05 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 34.33 | 11.29 | -16.06 | 5.63 | -10.91 |
Capital Expenditures CapEx Growth | - | -6.3 | -13.84 | -11.11 | -16.01 | -17.55 |
Free Cash Flow Free Cash Flow Growth | - | 28.04 | -2.56 | -27.17 | -10.38 | -28.46 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 16.60% | 14.45% | 15.90% | 17.35% | 24.61% | 24.41% |
Operating Margin | 7.07% | 7.26% | 3.63% | -2.61% | 3.06% | 3.49% |
Pretax Margin | 7.91% | 8.26% | 5.22% | 1.69% | -1.73% | 22.00% |
Profit Margin | 5.76% | 5.98% | 3.63% | 1.47% | -4.19% | 13.74% |
FCF Margin | - | 5.23% | -0.83% | -15.62% | -6.52% | -19.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.57 | 7.36 | 4.35 | 12.07 | - | 2.29 |
P/FCF Ratio | - | 8.42 | - | - | - | - |
PS Ratio | 0.67 | 0.44 | 0.16 | 0.18 | 0.14 | 0.32 |